{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:36:25Z","timestamp":1762868185095,"version":"build-2065373602"},"reference-count":64,"publisher":"Elsevier BV","issue":"35","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.vaccine.2020.06.083","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T03:05:44Z","timestamp":1593745544000},"page":"5564-5568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Bacillus Calmette\u2013Gu\u00e9rin vaccine,\u00a0antimalarial, age and gender relation to COVID-19 spread and mortality"],"prefix":"10.1016","volume":"38","author":[{"given":"Ahmed","family":"Osama El-Gendy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2040-9466","authenticated-orcid":false,"given":"Haitham","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed M.A.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossam M.","family":"Zawbaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina","family":"Gomaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadeer S.","family":"Harb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasmin M.","family":"Madney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasnaa","family":"Osama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona A.","family":"Abdelrahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0227-8404","authenticated-orcid":false,"given":"Mohamed E.A.","family":"Abdelrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.06.083_b0005","unstructured":"Worldometers.info. 2020 [cited 2020 17 May, 2020]; Available from: https:\/\/www.worldometers.info\/coronavirus\/."},{"issue":"9","key":"10.1016\/j.vaccine.2020.06.083_b0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030343","article-title":"SARS: Systematic Review of Treatment Effects","volume":"3","author":"Stockman","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2020.06.083_b0015","doi-asserted-by":"crossref","unstructured":"Azhar, E.I., et al., Evidence for camel-to-human transmission of MERS coronavirus. 2014. 370(26): p. 2499-2505","DOI":"10.1056\/NEJMoa1401505"},{"key":"10.1016\/j.vaccine.2020.06.083_b0020","series-title":"Circumstances and consequences of cross-species transmission","first-page":"325","article-title":"Bats civets and the emergence of SARS, in Wildlife and emerging zoonotic diseases: the biology","author":"Wang","year":"2007"},{"key":"10.1016\/j.vaccine.2020.06.083_b0025","unstructured":"Organization, W.H., Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations: scientific brief, 27 March 2020, 2020, World Health Organization."},{"key":"10.1016\/j.vaccine.2020.06.083_b0030","doi-asserted-by":"crossref","first-page":"105730","DOI":"10.1016\/j.envint.2020.105730","article-title":"Airborne transmission of SARS-CoV-2: The world should face the reality","volume":"139","author":"Morawska","year":"2020","journal-title":"Environ Int"},{"issue":"4","key":"10.1016\/j.vaccine.2020.06.083_b0035","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/s41591-020-0817-4","article-title":"Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding","volume":"26","author":"Xu","year":"2020","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.vaccine.2020.06.083_b0040","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1053\/j.gastro.2020.02.055","article-title":"Evidence for Gastrointestinal Infection of SARS-CoV-2","volume":"158","author":"Xiao","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.vaccine.2020.06.083_b0045","doi-asserted-by":"crossref","unstructured":"Chen, J., et al., Clinical progression of patients with COVID-19 in Shanghai, China. 2020","DOI":"10.1016\/j.jinf.2020.03.004"},{"key":"10.1016\/j.vaccine.2020.06.083_b0050","doi-asserted-by":"crossref","unstructured":"Huang, C., et al., Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. 2020. 395(10223): p. 497-506","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"10.1016\/j.vaccine.2020.06.083_b0055","doi-asserted-by":"crossref","unstructured":"Zhou, F., et al., Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. 2020.","DOI":"10.1016\/S0140-6736(20)30566-3"},{"key":"10.1016\/j.vaccine.2020.06.083_b0060","first-page":"368","article-title":"Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series","author":"Xiao-Wei","year":"2020","journal-title":"BMJ: British Med J (Online)"},{"issue":"11","key":"10.1016\/j.vaccine.2020.06.083_b0065","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1001\/jama.2020.1490","article-title":"2019 Novel Coronavirus\u2014Important Information for Clinicians","volume":"323","author":"del Rio","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2020.06.083_b0070","doi-asserted-by":"crossref","unstructured":"Lundgren, F., et al., Vaccination in the prevention of infectious respiratory diseases in adults. 2014. 60(1): p. 4-15.","DOI":"10.1590\/1806-9282.60.02.004"},{"issue":"12","key":"10.1016\/j.vaccine.2020.06.083_b0075","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/apa.13585","article-title":"The ongoing story of the Bacille Calmette-Gu\u00e9rin (BCG) vaccination","volume":"105","author":"Boman","year":"2016","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.vaccine.2020.06.083_b0080","first-page":"8(3)","article-title":"The BCG World Atlas: a database of global BCG vaccination policies and practices","author":"Zwerling","year":"2011","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2020.06.083_b0085","article-title":"Making sense of emerging evidence on the non-specific effects of the BCG vaccine on malaria risk and neonatal mortality","author":"Bassat","year":"2020","journal-title":"BMJ Specialist J."},{"issue":"2","key":"10.1016\/j.vaccine.2020.06.083_b0090","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.clinthera.2013.01.007","article-title":"Nonspecific effects of vaccines and the reduction of mortality in children","volume":"35","author":"Shann","year":"2013","journal-title":"Clinical Therapeut."},{"issue":"1","key":"10.1016\/j.vaccine.2020.06.083_b0095","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.vaccine.2014.07.110","article-title":"Measles\u2013mumps\u2013rubella vaccination and respiratory syncytial virus-associated hospital contact","volume":"33","author":"S\u00f8rup","year":"2015","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2020.06.083_b0100","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1542\/peds.2013-2218","article-title":"Acute lower respiratory infection among Bacille Calmette-Gu\u00e9rin (BCG)\u2013vaccinated children","volume":"133","author":"Hollm-Delgado","year":"2014","journal-title":"Pediatrics"},{"issue":"11","key":"10.1016\/j.vaccine.2020.06.083_b0105","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/cid\/civ144","article-title":"Nonspecific (heterologous) protection of neonatal BCG vaccination against hospitalization due to respiratory infection and sepsis","volume":"60","author":"de Castro","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2020.06.083_b0110","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiaa030","article-title":"Neonatal BCG vaccination reduces interferon gamma responsiveness to heterologous pathogens in infants from a randomised controlled trial","author":"Freyne","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.06.083_b0115","doi-asserted-by":"crossref","unstructured":"Zimmermann, P., A. Finn, and N. Curtis, Does BCG Vaccination Protect Against Nontuberculous Mycobacterial Infection? A Systematic Review and. 2018.","DOI":"10.1093\/infdis\/jiy207"},{"issue":"3","key":"10.1016\/j.vaccine.2020.06.083_b0120","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1136\/archdischild-2016-310760","article-title":"BCG vaccination at birth and early childhood hospitalisation: a randomised clinical multicentre trial","volume":"102","author":"Stensballe","year":"2017","journal-title":"Arch Dis Childhood"},{"key":"10.1016\/j.vaccine.2020.06.083_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(19)30625-5","article-title":"The status of tuberculosis vaccine development","author":"Schrager","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2020.06.083_b0130","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.chom.2011.04.006","article-title":"Trained immunity: a memory for innate host defense","volume":"9","author":"Netea","year":"2011","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.vaccine.2020.06.083_b0135","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","article-title":"BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity.","volume":"23","author":"Arts","year":"2018","journal-title":"Cell Host Microbe"},{"issue":"2","key":"10.1016\/j.vaccine.2020.06.083_b0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229287","article-title":"Monocytes from neonates and adults have a similar capacity to adapt their cytokine production after previous exposure to BCG and \u03b2-glucan","volume":"15","author":"Namakula","year":"2020","journal-title":"PLoS ONE"},{"issue":"6284","key":"10.1016\/j.vaccine.2020.06.083_b0145","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf1098","article-title":"Trained immunity: a program of innate immune memory in health and disease","volume":"352","author":"Netea","year":"2016","journal-title":"Science"},{"issue":"43","key":"10.1016\/j.vaccine.2020.06.083_b0150","doi-asserted-by":"crossref","first-page":"17537","DOI":"10.1073\/pnas.1202870109","article-title":"Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes","volume":"109","author":"Kleinnijenhuis","year":"2012","journal-title":"Proc National Academy Sci"},{"issue":"6204","key":"10.1016\/j.vaccine.2020.06.083_b0155","doi-asserted-by":"crossref","first-page":"1251086","DOI":"10.1126\/science.1251086","article-title":"Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity","volume":"345","author":"Saeed","year":"2014","journal-title":"Science"},{"issue":"6204","key":"10.1016\/j.vaccine.2020.06.083_b0160","doi-asserted-by":"crossref","first-page":"1250684","DOI":"10.1126\/science.1250684","article-title":"mTOR-and HIF-1\u03b1\u2013mediated aerobic glycolysis as metabolic basis for trained immunity","volume":"345","author":"Cheng","year":"2014","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.vaccine.2020.06.083_b0165","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1016\/j.celrep.2016.11.011","article-title":"Immunometabolic pathways in BCG-induced trained immunity","volume":"17","author":"Arts","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.vaccine.2020.06.083_b0170","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.3389\/fimmu.2019.02806","article-title":"BCG-induced cross-protection and development of trained immunity. Implication for vaccine design","volume":"10","author":"Covi\u00e1n","year":"2019","journal-title":"Front. Immunol"},{"key":"10.1016\/j.vaccine.2020.06.083_b0175","doi-asserted-by":"crossref","first-page":"970","DOI":"10.3389\/fimmu.2020.00970","article-title":"Could BCG vaccination induce protective trained immunity for SARS-CoV-2?","volume":"11","author":"Covi\u00e1n","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2020.06.083_b0180","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3389\/fimmu.2017.00644","article-title":"Whole blood profiling of bacillus Calmette\u2013Gu\u00e9rin-induced trained innate immunity in infants identifies epidermal growth factor, IL-6, platelet-derived growth factor-AB\/BB, and natural killer cell activation","volume":"8","author":"Smith","year":"2017","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2020.06.083_b0185","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1093\/infdis\/jiu508","article-title":"Heterologous immunological effects of early BCG vaccination in low-birth-weight infants in Guinea-Bissau: a randomized-controlled trial","volume":"211","author":"Jensen","year":"2015","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2020.06.083_b0190","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/infdis\/jix612","article-title":"Rapid protective effects of early BCG on neonatal mortality among low birth weight boys: observations from randomized trials","volume":"217","author":"Biering-S\u00f8rensen","year":"2018","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2020.06.083_b0195","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1146\/annurev.immunol.15.1.749","article-title":"Cellular responses to interferon-\u03b3","volume":"15","author":"Boehm","year":"1997","journal-title":"Ann Rev Immunol"},{"issue":"44","key":"10.1016\/j.vaccine.2020.06.083_b0200","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.1016\/j.vaccine.2009.08.031","article-title":"BCG vaccination reduces risk of infection with Mycobacterium tuberculosis as detected by gamma interferon release assay","volume":"27","author":"Eisenhut","year":"2009","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2020.06.083_b0205","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.cmi.2019.04.020","article-title":"Non-specific effects of BCG vaccine on viral infections","volume":"25","author":"Moorlag","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"10.1016\/j.vaccine.2020.06.083_b0210","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2019-001862","article-title":"BCG vaccination is associated with reduced malaria prevalence in children under the age of 5 years in sub-Saharan Africa","volume":"4","author":"Berendsen","year":"2019","journal-title":"BMJ Global Health"},{"issue":"922","key":"10.1016\/j.vaccine.2020.06.083_b0215","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1136\/pmj.78.922.449","article-title":"Use of bacille Calmette-Gu\u00e9rin in superficial bladder cancer","volume":"78","author":"Meyer","year":"2002","journal-title":"Postgraduate Med J"},{"issue":"3","key":"10.1016\/j.vaccine.2020.06.083_b0220","doi-asserted-by":"crossref","first-page":"168","DOI":"10.5489\/cuaj.10051","article-title":"Canadian guidelines for treatment of non-muscle invasive bladder cancer: a focus on intravesical therapy","volume":"4","author":"Kassouf","year":"2010","journal-title":"Canadian Urological Association J"},{"issue":"1","key":"10.1016\/j.vaccine.2020.06.083_b0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-16067-0","article-title":"Early vaccination protects against childhood leukemia: a systematic review and meta-analysis","volume":"7","author":"Morra","year":"2017","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.vaccine.2020.06.083_b0230","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.12014","article-title":"Association of BCG Vaccination in Childhood With Subsequent Cancer Diagnoses: A 60-Year Follow-up of a Clinical Trial","volume":"2","author":"Usher","year":"2019","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.vaccine.2020.06.083_b0235","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.atherosclerosis.2016.05.031","article-title":"BCG lowers plasma cholesterol levels and delays atherosclerotic lesion progression in mice","volume":"251","author":"van Dam","year":"2016","journal-title":"Atherosclerosis"},{"issue":"5296","key":"10.1016\/j.vaccine.2020.06.083_b0240","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1126\/science.275.5296.77","article-title":"The inverse association between tuberculin responses and atopic disorder","volume":"275","author":"Shirakawa","year":"1997","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.vaccine.2020.06.083_b0245","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S1081-1206(10)61890-X","article-title":"Therapeutic effects of BCG vaccination in adult asthmatic patients: a randomized, controlled trial","volume":"88","author":"Choi","year":"2002","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.vaccine.2020.06.083_b0250","article-title":"Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID- 19: an epidemiological study","author":"Miller","year":"2020","journal-title":"MedRxiv"},{"issue":"6","key":"10.1016\/j.vaccine.2020.06.083_b0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021566","article-title":"Systemic BCG immunization induces persistent lung mucosal multifunctional CD4 TEM cells which expand following virulent mycobacterial challenge","volume":"6","author":"Kaveh","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2020.06.083_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.cytogfr.2020.04.002","article-title":"Cytokine storm intervention in the early stages of COVID-19 pneumonia","author":"Sun","year":"2020","journal-title":"Cytokine Growth Factor Rev"},{"issue":"10229","key":"10.1016\/j.vaccine.2020.06.083_b0265","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2020.06.083_b0270","unstructured":"University, T.A.M. BCG Vaccine for Health Care Workers as Defense Against COVID 19 (BADAS). 2020 18.05.2020]; Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04348370."},{"key":"10.1016\/j.vaccine.2020.06.083_b0275","unstructured":"Institute, M.C.R. BCG Vaccination to Protect Healthcare Workers Against COVID-19 (BRACE). 2020 18.05.2020]; Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04327206."},{"key":"10.1016\/j.vaccine.2020.06.083_b0280","unstructured":"MJM Bonten and U. Utrecht. Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine (BCG-CORONA). 2020 18.05.2020]; Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04328441."},{"issue":"1","key":"10.1016\/j.vaccine.2020.06.083_b0285","article-title":"Social implications of malaria and their relationships with poverty","volume":"4","author":"Ricci","year":"2012","journal-title":"Mediterranean J Hematol Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2020.06.083_b0290","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/j.1365-2125.1989.tb03439.x","article-title":"Bioavailability of hydroxychloroquine tablets in healthy volunteers","volume":"27","author":"Tett","year":"1989","journal-title":"British J Clin Pharmacol"},{"key":"10.1016\/j.vaccine.2020.06.083_b0295","doi-asserted-by":"crossref","unstructured":"Wang, M., et al., Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. 2020. 30(3): p. 269-271.","DOI":"10.1038\/s41422-020-0282-0"},{"key":"10.1016\/j.vaccine.2020.06.083_b0300","doi-asserted-by":"crossref","unstructured":"Lotteau, V., et al., Intracellular transport of class II MHC molecules directed by invariant chain. 1990. 348(6302): p. 600-605.","DOI":"10.1038\/348600a0"},{"key":"10.1016\/j.vaccine.2020.06.083_b0305","doi-asserted-by":"crossref","unstructured":"Vincent, M.J., et al., Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. 2005. 2(1): p. 69.","DOI":"10.1186\/1743-422X-2-69"},{"key":"10.1016\/j.vaccine.2020.06.083_b0310","article-title":"COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression","author":"Zhou","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.vaccine.2020.06.083_b0315","doi-asserted-by":"crossref","unstructured":"Lopez-Izquierdo, A., et al., Chloroquine blocks a mutant Kir2. 1 channel responsible for short QT syndrome and normalizes repolarization properties in silico. 2009. 24(3-4): p. 153-160.","DOI":"10.1159\/000233241"},{"key":"10.1016\/j.vaccine.2020.06.083_b0320","doi-asserted-by":"crossref","unstructured":"Vereckei, A., et al., Chloroquine cardiotoxicity mimicking connective tissue disease heart involvement. 2013. 35(2): p. 304-306.","DOI":"10.3109\/08923973.2013.766801"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20308860?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20308860?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:46:05Z","timestamp":1759401965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20308860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":64,"journal-issue":{"issue":"35","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0264410X20308860"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.06.083","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bacillus Calmette\u2013Gu\u00e9rin vaccine,\u00a0antimalarial, age and gender relation to COVID-19 spread and mortality","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.06.083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}